Tau buildup and blood vessel disease in Mexican American adults with Alzheimer's

Cerebral tau deposition and comorbid cerebrovascular disease across the Alzheimer's disease continuum in Mexican Americans

NIH-funded research University of Texas Hlth Science Center · NIH-11169830

Using brain PET scans and AI, this project looks for tau protein buildup and cerebrovascular disease in Mexican American adults across the Alzheimer's spectrum to help detect disease earlier and predict memory decline.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center NIH-funded
Lab location1 site (San Antonio, United States)
Project IDNIH-11169830 on NIH RePORTER

What this research studies

You would receive specialized brain PET scans that show tau protein using a tracer (18F‑MK‑6240), plus MRI and cognitive testing. The team will apply advanced AI methods to map tau patterns and quantify how tau and blood vessel disease together relate to thinking and memory. They will enroll Mexican American adults across the Alzheimer's continuum and compare findings to other groups to better understand observed disparities. The study will also collect information on vascular risk factors and social determinants of health that may influence brain changes.

Who could benefit from this research

Good fit: Ideal candidates are Mexican American adults (21+) who are on the Alzheimer's disease spectrum, including people with mild cognitive impairment, Alzheimer disease dementia, or at elevated risk for AD.

Not a fit: People who cannot undergo PET or MRI imaging, are unwilling to participate in imaging and cognitive visits, or whose symptoms are due to non-Alzheimer causes may not directly benefit from this project.

Why it matters

Potential benefit: If successful, this work could help doctors detect Alzheimer's earlier and more accurately in Mexican American patients and account for coexisting vascular disease when planning care.

How similar studies have performed: Tau PET imaging and AI methods have improved detection and prognosis in other cohorts, but few studies have tested these approaches specifically in Mexican American populations.

Where this research is happening

San Antonio, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease detection
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.